Phase II trial of stereotactic body radiotherapy for non-spine bone metastases.

Phase II trial of stereotactic body radiotherapy for non-spine bone metastases. - SBRT for non-spine bone mets.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033132

Enrollment

Registered

2018-06-25

Start date

2018-06-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-spine bone metastases

Interventions

SBRT of 35 Gy in 5 fractions for painful non-spine bone metastases

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. pathological or clinical diagnosis of non-spine bone metastases 2. painful non-spine metastases with NRPS of 2 or more 3. An hour resting in supine is possible 4. Age; 20- 5. Expected prognosis; 6 months or more 6. Written informed consent

Exclusion criteria

Exclusion criteria: 1. The lesion is skull base bone 2. The lesion is radiosensitive tumor 3. Radiation history in the same area with 3 months 4. Serious medical or psychological problems

Design outcomes

Primary

Measure	Time frame
Pain-progression free rate at 6 months	—

Countries

Japan

Contacts

Public ContactKei Ito

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Radiation Oncology

keiito@cick.jp03-3823-2101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026